Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Interleukin 1, a prototypic pleiotropic lymphokine.

P Ghezzi1, A Mantovani

  • 1Istituto di Ricerche Farmacologiche Mario Negri, Milan, Italy.

Annali Dell'Istituto Superiore Di Sanita
|January 1, 1990
PubMed
Summary

Interleukin 1 (IL-1) acts as both an immune stimulant and a mediator of inflammation and shock. Understanding its dual role is key for developing new therapies for inflammatory diseases.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Truncation of macrophage-derived chemokine by CD26/ dipeptidyl-peptidase IV beyond its predicted cleavage site affects chemotactic activity and CC chemokine receptor 4 interaction.

The Journal of biological chemistry·1999
Same author

Up-regulation of CCR1 and CCR3 and induction of chemotaxis to CC chemokines by IFN-gamma in human neutrophils.

Journal of immunology (Baltimore, Md. : 1950)·1999
Same author

Regulation of endothelial cell function by pro- and anti-inflammatory cytokines.

Transplantation proceedings·1998
Same author

Regulation of chemokine receptor expression in dendritic cells.

Research in immunology·1998
Same author

The viral chemokine macrophage inflammatory protein-II is a selective Th2 chemoattractant.

Blood·1998
Same author

Interleukin-1beta and interferon-gamma differentially regulate release of monocyte chemotactic protein-1 and interleukin-8 by human bronchial epithelial cells.

European cytokine network·1998

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Interleukin 1 (IL-1) is an endogenous mediator produced by various cell types, including monocytes/macrophages and endothelial cells.
  • Initially identified as the main endogenous pyrogen, IL-1 is also known as leukocytic endogenous mediator and lymphocyte-activating factor.
  • IL-1 exhibits a dual role, functioning as an immunostimulatory molecule and a mediator of shock and inflammation.

Purpose of the Study:

  • To elucidate the multifaceted roles of Interleukin 1 (IL-1) in biological processes.
  • To explore the potential of IL-1 as an immuno-modulating drug.
  • To identify antagonists or inhibitors of IL-1's proinflammatory actions for therapeutic applications.

Main Methods:

  • Literature review and synthesis of existing research on Interleukin 1 (IL-1).
  • Analysis of IL-1's molecular functions and cellular origins.
  • Evaluation of IL-1's involvement in immune responses and inflammatory pathways.

Main Results:

  • Interleukin 1 (IL-1) is a key mediator with significant roles in both immune stimulation and inflammatory processes.
  • Its immunostimulatory properties suggest potential applications in immuno-modulating therapies.
  • Its proinflammatory actions highlight the need for therapeutic strategies targeting IL-1 in chronic inflammatory diseases.

Conclusions:

  • Interleukin 1 (IL-1) possesses a critical dual function in the immune system and inflammatory responses.
  • Targeting IL-1 offers promising avenues for the development of novel therapeutic agents for immune and inflammatory conditions.
  • Further research into IL-1 antagonists and inhibitors is warranted for managing chronic inflammatory diseases.

Related Experiment Videos